lestaurtinib has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kangussu-Marcolino, MM; Singh, U | 1 |
| Antar, AI; Bazarbachi, A; Jabbour, E; Mohty, M; Otrock, ZK | 1 |
1 review(s) available for lestaurtinib and Local Neoplasm Recurrence
| Article | Year |
|---|---|
FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions.
Topics: Aniline Compounds; Antineoplastic Agents; Benzimidazoles; Benzothiazoles; Carbazoles; DNA Methylation; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Furans; Humans; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Phenylurea Compounds; Piperidines; Prognosis; Pyrazines; Randomized Controlled Trials as Topic; Sorafenib; Staurosporine; Treatment Outcome | 2020 |
1 other study(ies) available for lestaurtinib and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Ponatinib, Lestaurtinib, and mTOR/PI3K Inhibitors Are Promising Repurposing Candidates against Entamoeba histolytica.
Topics: Animals; Carbazoles; Drug Repositioning; Entamoeba histolytica; Female; Furans; Humans; Imidazoles; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Pregnancy; Pyridazines; TOR Serine-Threonine Kinases | 2022 |